ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Clinical and Pathologic Characteristics of Acute Rejection After Alemtuzumab Induction in Kidney Transplant Recipients.

    P. Zhang,1 H. Amer,2 C. Schinstock,2 M. Alexander,1 F. Cosio,2 M. Stegall,3 L. Cornell.1

    1Anatomic Pathology, Mayo Clinic, Rochester; 2Nephrology, Mayo Clinic, Rochester; 3Transplant Surgery, Mayo Clinic, Rochester

    Background: Alemtuzumab induction (AZI) can be used for early steroid withdrawal in kidney transplant (KTx) recipients. There is evidence that AZI-induced lymphocyte depletion leads to…
  • 2017 American Transplant Congress

    Infections and Outcomes in Renal Transplantation Patients Using Alemtuzumab for Induction Immunosuppression: Preliminary Results.

    K. Korneffel, B. Gehring, G. Mitro, O. Aboderin, S. Makkar, W. Han, M. Rees, J. Ortiz.

    Surgery, University of Toledo College of Medicine, Toledo, OH

    Introduction: Alemtuzumab (Ale) is a monoclonal antibody targeting CD52+ lympocytes. We sought to determine the impact of Ale immunodepletion, with steroid freedom for low risk…
  • 2017 American Transplant Congress

    Predictive Value of Post Reperfusion TEG in Peri-Operative Outcomes During Liver Transplant.

    P. Sheiner, A. Sulejamnovic, J. Salm, E. Silver, C. Rochon.

    Transplant Surgery, Hartford Hospital, Hartford, CT

    Liver transplantation (LT) is the main treatment for patients with end-stage liver disease. During a liver transplant, persistent coagulations defects and fibrinolysis can be an…
  • 2017 American Transplant Congress

    Diabetes in Liver Transplantation: Evaluation of Management and Associated Clinical Outcomes.

    A. Rogers,2 N. Patel,2 H. Meadows,2 A. Mardis,2 J. Fleming,2 C. Perez,2 I. Lee,2 M. Sell,2 B. O'Brien,2 D. Taber,1 K. Chavin,1 D. Dubay,1 C. Mardis,2 N. Pilch.1

    1Department of Surgry Division of Transplant, Medical University of South Carolina, Charleston, SC; 2Department of Pharmacy, Medical University of South Carolina, Charleston, SC

    PurposeThere is limited data with diabetes management in liver transplant recipients and associated outcomes, this study aims to evaluate the long-term diabetes management in this…
  • 2017 American Transplant Congress

    Technique and Result of Anastomosing Right Hepatic Vein to Inferior Vena Cava with a Separate Cavotomy Inferior to Right Hepatic Vein Orfice.

    R. Rai, E. Trivedi, I. Shaikh, S. Nagral, N. Doctor.

    HPB & Transplant Surgery, Fortis Hospital, Mulund, Mumbai, Maharashtra, India

    From January 2013 to February 2016 total of 21 patients underwent consecutive Living Donor Liver Transplant in our center. All patients were transplanted using right…
  • 2017 American Transplant Congress

    Propensity-Score Matched Comparison of Lung Transplant Recipients of Age <70 and ≥70 Years.

    A. Kashem,1 S. Keshavamurthy,1 J. Gomez-Abraham,1 T. Yoshizumi,1 H. Zhao,2 F. Cordova,3 G. Criner,3 Y. Toyoda.1

    1Cardiovascular Surgery, Temple University, Philadelphia, PA; 2Clinical Sciences, Temple University, Philadelphia, PA; 3Thoracic and Pulmonary Medicine, Temple University, Philadelphia, PA

    Purpose: To validate the utilization of lung transplantation (LTx) recently in older recipients, we compared the survival outcome of the LTx recipients of age <70…
  • 2017 American Transplant Congress

    A Pilot Test of the "Individualized Self-Management Training in Adolescent/Young Adult Recipients of Transplantation (iSTART)" Program.

    E. Fredericks, S. Eder, D. Egleston, W. Newhouse, D. O'Reilly, G. Freed, J. Magee, K. Resnicow.

    University of Michigan, Ann Arbor

    Objective: To pilot test the feasibility and impact of the iSTART program on medication adherence, quality of life, and medication barriers among adolescent/young adult (AYA)…
  • 2017 American Transplant Congress

    Rapid Regression of Xanthomata After Orthotopic Liver Tranplantation for Alagille Syndrome.

    N. Galvan,1 P. Nguyen,1 S. Koohmaraie,2 R. Cotton,1 A. Rana,1 C. O'Mahony,1 J. Goss.1

    1Division of Abdominal Transplant, Baylor College of Medicine, Houston, TX; 2Texas Children's Hospital, Houston, TX

    Arteriohepatic dysplasia, or Alagille syndrome, is a genetic disorder characterized by chronic cholestasis in the setting of multiple congenital abnormalities of different organ systems, including…
  • 2017 American Transplant Congress

    A Clinically Relevant Protocol for Vascularized Composite Allotransplantation Using a Single Dose of AMD3100 for Stem Cell Mobilization.

    B. Swearingen,1,2 S. Graves,2,3 R. Storb,2,3 D. Mathes.1,2

    1Surgery, Division of Plastic and Reconstructive Surgery, University of Colorado School of Medicine, Aurora, CO; 2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; 3Medicine, University of Washington Medical Center, Seattle, WA

    BACKGROUND: Vascularized Composite Allograft (VCA) transplantation is a clinical reality but application is limited by toxicities of chronic immunosuppression and rejection. Current clinical tolerance protocols…
  • 2017 American Transplant Congress

    Triptolide Alleviating Acute Antibody Mediated Rejection by Inhibition of B Cell Activation in Presensitized Recipients.

    D. Zhao,1 S. Li,1 T. Liao,1 Y. Wei,2 X. Hua,1 F. Han,1 Z. Luo,1 X. Liu,1 Q. Sun.

    1Kidney Transplantation, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China; 2Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, Guangdong, China

    Backgroud: Acute antibody mediated rejection (AMR), resistant to most anti-rejection therapy, is main cause for renal graft loss. Triptolide(TPL) had been reported as a promising…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences